12-Month Lobbying Summary - Organization

MERCK CANADA INC. / David Jones, President and Managing Director

Registration Summary

Currently active - Last Updated: 2024-09-01

Who is lobbying?

MERCK CANADA INC. (Address & business activities)

David Jones, President and Managing Director

Senior Officer in previous versions
- Marwan Akar, President and Managing Director

Government Funding

Did MERCK CANADA INC. request or receive government funding within the last 12 months? No

Coalition Members Information

MERCK CANADA INC. is not a coalition member.

Direct Interests of the Lobbying Activity

Affiliates

MERCK CANADA INC. has the following affiliates that could have a direct interest in the outcome of the lobbying activities:

Merck & Co. (Address information)

Other Affiliates

The activities of MERCK CANADA INC. are not controlled or directed by another person or organization with a direct interest in the outcome of this undertaking

Contributors with a Direct Interest in the Outcome

No person or organization contributed over $1000CDN, within the preceding 12 months, toward the lobbying activity on behalf of MERCK CANADA INC.:

What is being lobbied?

Subject Matter of the Lobbying Activities

Details Regarding the Identified Subject Matter

Will any of the lobbyists listed within this registration arrange a meeting between a public office holder and any other individual for the purpose of attempting to influence any of the matters listed below:

Yes

Subject matters added through an Lobbying Activity Report:
Specific Topics of Lobbying Communications	Intended Outcomes	Associated Subject Matters
Communicate with BC government about conditions under which innovative drugs and vaccines are marketed and reimbursed in BC, including under the BC Drug Plans or under federal legislation. In particular, communicating to emphasize the importance that federal and provincial governments respect their respective jurisdiction for approval of marketing and reimbursement of drugs.	Development of any legislative proposal by the government of British Columbia, a Provincial entity or a member of the Legislative Assembly Development or enactment of any regulation, including the enactment of a regulation for the purposes of amending or repealing a regulation Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity Decision by the Executive Council or a member of the Executive Council to have the private sector instead of the Crown provide goods or services to the government of British Columbia or a Provincial entity	Health
Communicate with BC government to leverage BC programs and related resources/tools as a best practice in other markets.	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Health
Communicate with BC government to preserve a regulatory framework which creates a favourable business environment for the development of the life science sector, including innovative drugs and vaccines.	Development of any legislative proposal by the government of British Columbia, a Provincial entity or a member of the Legislative Assembly Development or enactment of any regulation, including the enactment of a regulation for the purposes of amending or repealing a regulation Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity Decision by the Executive Council or a member of the Executive Council to have the private sector instead of the Crown provide goods or services to the government of British Columbia or a Provincial entity	Health
Discuss legislation enacted or proposed to ensure that innovative drugs are excluded from the tendering process covered by such legislation until the expiry of the period covered by their patents.	Development of any legislative proposal by the government of British Columbia, a Provincial entity or a member of the Legislative Assembly Development or enactment of any regulation, including the enactment of a regulation for the purposes of amending or repealing a regulation Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity Decision by the Executive Council or a member of the Executive Council to have the private sector instead of the Crown provide goods or services to the government of British Columbia or a Provincial entity	Health
Engage BC government on Merck’s commercial product/asset pipeline and seek access listing agreements.	Development of any legislative proposal by the government of British Columbia, a Provincial entity or a member of the Legislative Assembly Development or enactment of any regulation, including the enactment of a regulation for the purposes of amending or repealing a regulation Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity Decision by the Executive Council or a member of the Executive Council to have the private sector instead of the Crown provide goods or services to the government of British Columbia or a Provincial entity	Health
Seeking recommendation for Merck vaccine product through Immunization and Vaccine Preventable Disease Service Program under the Provincial Health Services Authority.	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Health
Subject matters added through an Lobbying Activity Report:
Communicate with BC government about conditions under which innovative drugs and vaccines are marketed and reimbursed in BC, including under the BC Drug Plans or under federal legislation. In particular, communicating to emphasize the importance that federal and provincial governments respect their respective jurisdiction for approval of marketing and reimbursement of drugs.	Development of any legislative proposal by the government of British Columbia, a Provincial entity or a member of the Legislative Assembly Development or enactment of any regulation, including the enactment of a regulation for the purposes of amending or repealing a regulation Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity Decision by the Executive Council or a member of the Executive Council to have the private sector instead of the Crown provide goods or services to the government of British Columbia or a Provincial entity	Health

Gifts or benefits provided by the organization

Gifts or Benefits Provided to Public Officer Holders
Name	Gift or Benefit Description	Circumstance	Date Promised	Value Promised	Date Given	Value Given
No Records

Who is being lobbied?

Ministries/Provincial Entities

Health
Jobs, Economic Development and Innovation
Member(s) of the BC Legislative Assembly
Provincial Health Services Authority
University of British Columbia

Who are the lobbyists?

In-house Lobbyists

Lobbyist

Contributions

Jennifer Chan
Subscribes to a Code of Conduct: No
Former Public Office Holder in BC: No

Lobbied a member of the Legislative Assembly, including a Minister or Premier, on behalf of this organization on or after 2020-09-21 and before 2024-09-21: Yes	Political: No Sponsorship: No Recall: No
Lobbied or plans to lobby a member of the Legislative Assembly, including a Minister or Premier, on behalf of this organization, on or after 2024-09-21: Yes	Political: No Sponsorship: No Recall: No

Chantal Desbiens
Subscribes to a Code of Conduct: No
Former Public Office Holder in BC: No

Lobbied a member of the Legislative Assembly, including a Minister or Premier, on behalf of this organization on or after 2020-09-21 and before 2024-09-21: Yes	Political: No Sponsorship: No Recall: No
Lobbied or plans to lobby a member of the Legislative Assembly, including a Minister or Premier, on behalf of this organization, on or after 2024-09-21: Yes	Political: No Sponsorship: No Recall: No

Leslie Foord
Subscribes to a Code of Conduct: No
Former Public Office Holder in BC: No

Lobbied a member of the Legislative Assembly, including a Minister or Premier, on behalf of this organization on or after 2020-09-21 and before 2024-09-21: Yes	Political: No Sponsorship: No Recall: No
Lobbied or plans to lobby a member of the Legislative Assembly, including a Minister or Premier, on behalf of this organization, on or after 2024-09-21: Yes	Political: No Sponsorship: No Recall: No

Jeff Guiler
Subscribes to a Code of Conduct: No
Former Public Office Holder in BC: No

Lobbied a member of the Legislative Assembly, including a Minister or Premier, on behalf of this organization on or after 2020-09-21 and before 2024-09-21: Yes	Political: No Sponsorship: No Recall: No
Lobbied or plans to lobby a member of the Legislative Assembly, including a Minister or Premier, on behalf of this organization, on or after 2024-09-21: Yes	Political: No Sponsorship: No Recall: No

Chad Jarema
Subscribes to a Code of Conduct: No
Former Public Office Holder in BC: No

Lobbied a member of the Legislative Assembly, including a Minister or Premier, on behalf of this organization on or after 2020-09-21 and before 2024-09-21: Yes	Political: No Sponsorship: No Recall: No
Lobbied or plans to lobby a member of the Legislative Assembly, including a Minister or Premier, on behalf of this organization, on or after 2024-09-21: Yes	Political: No Sponsorship: No Recall: No

David Jones
Subscribes to a Code of Conduct: No
Former Public Office Holder in BC: No

Lobbied a member of the Legislative Assembly, including a Minister or Premier, on behalf of this organization on or after 2020-09-21 and before 2024-09-21: No
Lobbied or plans to lobby a member of the Legislative Assembly, including a Minister or Premier, on behalf of this organization, on or after 2024-09-21: Yes	Political: No Sponsorship: No Recall: No

Lonnie Kam
Subscribes to a Code of Conduct: No
Former Public Office Holder in BC: No

Lobbied a member of the Legislative Assembly, including a Minister or Premier, on behalf of this organization on or after 2020-09-21 and before 2024-09-21: Yes	Political: No Sponsorship: No Recall: No
Lobbied or plans to lobby a member of the Legislative Assembly, including a Minister or Premier, on behalf of this organization, on or after 2024-09-21: Yes	Political: No Sponsorship: No Recall: No

Wes Miyai
Subscribes to a Code of Conduct: No
Former Public Office Holder in BC: No

Lobbied a member of the Legislative Assembly, including a Minister or Premier, on behalf of this organization on or after 2020-09-21 and before 2024-09-21: Yes	Political: No Sponsorship: No Recall: No
Lobbied or plans to lobby a member of the Legislative Assembly, including a Minister or Premier, on behalf of this organization, on or after 2024-09-21: Yes	Political: No Sponsorship: No Recall: No

Heidi Waser
Subscribes to a Code of Conduct: No
Former Public Office Holder in BC: No

Lobbied a member of the Legislative Assembly, including a Minister or Premier, on behalf of this organization on or after 2020-09-21 and before 2024-09-21: Yes	Political: No Sponsorship: No Recall: No
Lobbied or plans to lobby a member of the Legislative Assembly, including a Minister or Premier, on behalf of this organization, on or after 2024-09-21: Yes	Political: No Sponsorship: No Recall: No

Lobbyists in previous versions

In-house Lobbyists
Lobbyist	BC Former Public Office Holder Positions	Contributions
Marwan Akar	Former Public Office Holder in BC: No	Contributions: No
Lauren Allen	Former Public Office Holder in BC: No	Contributions: No
Sevag Sahakian	Former Public Office Holder in BC: No	Contributions: No
Lee Swift	Former Public Office Holder in BC: No	Contributions: No

Registration number: 10680-2093
View all registrations versions

Lobbying Activity Reports

What lobbying activities have taken place in the last 12 months?

What lobbying activities have taken place in the last 12 months?
Date	Arranging a Meeting	Lobbyists	Senior Public Office Holder, Position Title \| Ministry/Provincial Entity	Subject Matters
2024-09-05	No	Wes Miyai	Kelly Greene, MLA for Richmond-Steveston \| Member(s) of the BC Legislative Assembly	View

View all Lobbying Activity Reports

Return to 12-Month Lobbying Activity Search Results

MERCK CANADA INC. - Address & business activities

Address:

16750 TransCanada Highway
Kirkland, QC H9H 4M7
Canada

Telephone number: 438-920-8356

Contact information in previous versions
- 16750 TransCanada Highway
  Kirkland, QC H9H 4M7
  Canada
  
  Telephone number: 514-428-2638
- 16750 TransCanada Highway
  Kirkland, QC H9H 4M7
  Canada
  
  Telephone number: 514-515-1009
- 16750 TransCanada Highway
  Kirkland, QC H9H 4M7
  Canada
  
  Telephone number: 514-428-2638
  
  Fax number: 514-428-2662
- 16750 TransCanada Highway
  Kirkland, BC H9H 4M7
  Canada
  
  Telephone number: 604-643-7996
  
  Fax number: 604-643-7900
- 16750 TransCanada Highway
  
  Kirkland, BC H9H 4M7
  Canada
  
  Telephone number: 604-643-7996
  
  Fax number: 604-643-7900
- 16750 TransCanada Highway
  
  Kirkland, QC H9H 4M7
  Canada
  
  Telephone number: 604-643-7996
  
  Fax number: 604-643-7900
- 16750 TransCanada Highway
  
  Kirkland, BC H9H 4M7
  Canada
  
  Telephone number: 604-643-5885
  
  Fax number: 604-643-7900
- 16750 TransCanada Highway
  
  Kirkland, QC H9H 4M7
  Canada
  
  Telephone number: 604-643-5978
  
  Fax number: 604-622-5619
- 5033 Marguerite Street
  
  Vancouver, BC V6M 3G9
  Canada
  
  Telephone number: 604-643-5978
  
  Fax number: 604-622-5619
- 5033 Marguerite Street
  
  Vancouver, BC V6M 3G9
  Canada
  
  Telephone number: 604-643-5913
- 383 37th Avenue, Apt #430
  
  Vancouver, BC V5W 4C1
  Canada
  
  Telephone number: 604-643-5913

Description of Activities:
For more than 130 years, Merck, known as MSD outside of the United States and Canada, has been inventing for life, bringing forward medicines and vaccines for many of the world’s most challenging diseases in pursuit of our mission to save and improve lives. We demonstrate our commitment to patients and population health by increasing access to health care through far-reaching policies, programs and partnerships. Today, Merck continues to be at the forefront of research to prevent and treat diseases that threaten people and animals – including cancer, infectious diseases such as HIV and Ebola, and emerging animal diseases – as we aspire to be the premier research-intensive biopharmaceutical company in the world. In Canada, Merck markets a broad range of vaccines, pharmaceutical and animal health products and is one of the top R&D investors in Canada, with investments totaling $93.58 million in 2020 and more than $1.3 billion since 2000. Based in Kirkland, Québec, Merck employs approximately 592 people across the country. For more information about our operations in Canada, visit www.merck.ca and connect with us on YouTube and Twitter @MerckCanada.

Descriptions of the organization's activity in previous versions:
- For over a century, Merck, a leading global biopharmaceutical company known as MSD outside of the United States and Canada, has been inventing for life, bringing forward medicines and vaccines for many of the world's most challenging diseases. Through our prescription medicines, vaccines, biologic therapies and animal health products, we work with customers and operate in more than 140 countries to deliver innovative health solutions. We also demonstrate our commitment to increasing access to health care through far-reaching policies, programs and partnerships. Today, Merck continues to be at the forefront of research to advance the prevention and treatment of diseases that threaten people and communities around the world - including cancer, cardio-metabolic diseases, emerging animal diseases, Alzheimer's disease and infectious diseases including HIV and Ebola. For more information about our operations in Canada, visit www.merck.ca and connect with us on YouTube and Twitter @MerckCanada.
- For over a century, Merck has been working to help the world be well. Merck is a global health care leader with a diversified portfolio of prescription medicines, vaccines, biologic therapies, and animal health products. In Canada, Merck markets more than 250 pharmaceutical and animal health products. Merck is a leader in a broad range of areas such as oncology, infectious diseases, diabetes, and vaccines. Based in Montréal, Québec, Merck employs approximately 810 people across Canada. Merck is one of the top R&D investors in Canada, with investments totaling $25.1 million in 2015 and more than $1 billion since 2000. For more information about our operations in Canada, visit www.merck.ca and connect with us on YouTube and Twitter @MerckCanada.
- For 125 years, Merck has been working to help the world be well. Merck is a global health care leader with a diversified portfolio of prescription medicines, vaccines and animal health products. In Canada, Merck markets more than 250 pharmaceutical and animal health products. Merck is a leader in a broad range of areas such as cardiology, infectious diseases, respiratory, vaccines and women's health, and is focused on expanding offerings in other areas, including virology, oncology and diabetes. Based in Montréal, Québec, Merck employs approximately 795 people across Canada. Merck is one of the top R&D investors in Canada, with investments totalling $29.9 million in 2014 and more than $1 billion since 2000. For more information about our operations in Canada, visit www.merck.ca and connect with us on YouTube.
- Today's Merck is working to help the world be well. Merck is a global health care leader with a diversified portfolio of prescription medicines, vaccines and animal health products. In Canada, Merck markets more than 250 pharmaceutical and animal health products. Merck is a leader in a broad range of areas such as cardiology, infectious diseases, respiratory, vaccines and women's health, and is focused on expanding offerings in other areas, including virology, oncology and diabetes. Based in Montreal, Quebec, Merck employs approximately 775 people across Canada. Merck is one of the top R+D investors in Canada, with investments totalling $22.6 million in 2013 and more than $1 billion since 2000. For more information about our operations in Canada, visit www.merck.ca.
- Today's Merck is working to help the world be well. Merck is a global health care leader with a diversified portfolio of prescription medicines, vaccines and animal health products. In Canada, Merck markets more than 250 pharmaceutical and animal health products. Merck is a leader in a broad range of areas such as cardiology, infectious diseases, respiratory, vaccines and women's health, and is focused on expanding offerings in other areas, including virology, oncology and diabetes. Based in Montréal, Québec, Merck employs approximately 975 people across Canada. The Merck Canada manufacturing facility in Québec has been designated by its parent company as a Centre of Excellence for the global production of liquids, ointments and creams. Merck is one of the top R&D investors in Canada, with investments totalling $22.6 million in 2013 and more than $1 billion since 2000. For more information about our operations in Canada, visit www.merck.ca.
- Today's Merck is working to help the world be well. Merck is a global health care leader with a diversified portfolio of prescription medicines, vaccines, consumer care and animal health products. In Canada, Merck markets more than 530 pharmaceutical, consumer care and animal health products. Merck is a leader in a broad range of areas such as cardiology, infectious diseases, respiratory, vaccines, women's health and sun care, and is focused on expanding offerings in other areas, including virology, oncology and diabetes. Based in Montréal, Québec, Merck employs approximately 1150 people across Canada. The Merck Canada manufacturing facility in Québec has been designated by its parent company as a Centre of Excellence for the global production of liquids, ointments and creams. Merck is one of the top R&D investors in Canada, with investments totalling $39.7 million in 2012 and more than $1 billion since 2000. For more information about our operations in Canada, visit www.merck.ca.
- Today's Merck is working to help the world be well. Merck is a global health care leader with a diversified portfolio of prescription medicines, vaccines, consumer and animal health products. In Canada, Merck markets over 530 pharmaceutical, consumer and animal health products. Merck is a leader in a broad range of areas such as cardiology, infectious diseases, respiratory, vaccines, women's health and sun care, and is focused on expanding offerings in other areas, including virology, oncology and diabetes. Merck is one of the top R&D investors in Canada, with an investment of $78.6 million in 2010. Merck has a large manufacturing facility in Québec dedicated to the annual production of some 35 million units of its various brands, including Claritin® and Aerius®. Based in Montréal, Québec, Merck employs over 1400 people across Canada. For more information about our operations in Canada, visit www.merck.ca.
- Today's Merck is working to help the world be well. Merck is a global health care leader with a diversified portfolio of prescription medicines, vaccines, consumer and animal health products. In Canada, Merck markets over 530 pharmaceutical, consumer and animal health products and is a leader in a broad range of areas such as cardiology, immunology, infectious diseases, respiratory, vaccines, women's health and sun care, and is focused on expanding offerings in other areas, including virology, oncology and diabetes. Merck is one of the top 25 R&D investors in Canada, with an investment of $95.4 million in 2009. Merck also has a large manufacturing facility in Quebec dedicated to the annual production of some 35 million units including the Claritin and Aerius brands. Based in Montréal, Quebec, Merck employs over 1600 people across Canada. For more information about our operations in Canada, visit www.merck.ca. *Merck Frosst Canada Ltd. and Schering-Plough Canada Inc. are integrating their operations to form a new organization called Merck.
- Merck is a global health care leader with a diversified portfolio of prescription medicines, vaccines, consumer and animal health products. In Canada, Merck markets over 530 pharmaceutical, consumer and animal health products and is a leader in a broad range of areas such as cardiology, immunology, infectious diseases, respiratory, vaccines, women's health and sun care, and is focused on expanding offerings in other areas, including virology, oncology and diabetes. Merck is one of the top 25 R&D investors in Canada, with an investment of $121 million in 2008 and has one of the largest biomedical research facilities in Canada with the mandate to discover new therapies for the treatment of infectious diseases. Merck also has a large manufacturing facility in Quebec dedicated to the annual production of some 35 million units including the Claritin and Aerius brands. Based in Montréal, Quebec, Merck employs over 1800 people across Canada. For more information about our operations in Canada visit www.merckfrosst.com.

Date Modified:: 2024-10-03

Menus

www.lobbyistsregistrar.bc.ca

12-Month Lobbying Summary - Organization

MERCK CANADA INC. / David Jones, President and Managing Director

Who is lobbying?

MERCK CANADA INC. (Address & business activities)

Government Funding

Coalition Members Information

Direct Interests of the Lobbying Activity

Affiliates

Other Affiliates

Contributors with a Direct Interest in the Outcome

What is being lobbied?

Details Regarding the Identified Subject Matter

Subject matters added through an Lobbying Activity Report:

Gifts or benefits provided by the organization

Who is being lobbied?

Ministries/Provincial Entities

Who are the lobbyists?

What lobbying activities have taken place in the last 12 months?

12-Month Lobbying Summary - Organization

MERCK CANADA INC. / David Jones, President and Managing Director

MERCK CANADA INC. (Address & business activities)

Government Funding

Coalition Members Information

Direct Interests of the Lobbying Activity

Affiliates

Other Affiliates

Contributors with a Direct Interest in the Outcome

Details Regarding the Identified Subject Matter

Subject matters added through an Lobbying Activity Report:

Gifts or benefits provided by the organization

Ministries/Provincial Entities

MERCK CANADA INC. - Address & business activities

MERCK CANADA INC. / David Jones, President and Managing Director

Merck & Co.